Citation only
via OpenAlex
Forecasting Age-Related Macular Degeneration Through the Year 2050
Archives of Ophthalmology · 2009 · ▲ 345 citations
Abstract
OBJECTIVE: To forecast age-related macular degeneration (AMD) and its consequences in the United States through the year 2050 with different treatment scenarios. METHODS: We simulated cases of early AMD, choroidal neovascularization (CNV), geographic atrophy (GA), and AMD-attributable visual impairment and blindness with 5 universal treatment scenarios: (1) no treatment; (2) focal laser and photodynamic therapy (PDT) for CNV; (3) vitamin prophylaxis at early-AMD incidence with focal laser/PDT for CNV; (4) no vitamin prophylaxis followed by focal laser treatment for extra and juxtafoveal CNV and anti-vascular endothelial growth factor treatment; and (5) vitamin prophylaxis at early-AMD incidence followed by CNV treatment, as in scenario 4. RESULTS: Cases of early AMD increased from 9.1 million in 2010 to 17.8 million in 2050 across all scenarios. In non-vitamin-receiving scenarios, cases of CNV and GA increased from 1.7 million in 2010 to 3.8 million in 2050 (25% lower in vitamin-receiving scenarios). Cases of visual impairment and blindness increased from 620 000 in 2010 to 1.6 million in 2050 when given no treatment and were 2.4%, 22.0%, 16.9%, and 34.5% lower in scenarios 2, 3, 4, and 5, respectively. CONCLUSION: Prevalence of AMD will increase substantially by 2050, but the use of new therapies can mitigate its effects.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1001/archophthalmol.2009.58
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Rein, D.B. (2009). Forecasting Age-Related Macular Degeneration Through the Year 2050. <em>Archives of Ophthalmology</em>. https://doi.org/10.1001/archophthalmol.2009.58
Vancouver
Rein DB. Forecasting Age-Related Macular Degeneration Through the Year 2050. Archives of Ophthalmology. 2009. doi:10.1001/archophthalmol.2009.58.
BibTeX
@article{david2009Foreca,
title = {Forecasting Age-Related Macular Degeneration Through the Year 2050},
author = {David B. Rein},
journal = {Archives of Ophthalmology},
year = {2009},
doi = {10.1001/archophthalmol.2009.58},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Association for Innovation and Biomedical Research on Light and Image 2005
Open access · US-GOV
Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers)
Peking University 2010
Open access · US-GOV
The Effects of Lutein and Zeaxanthin Supplementations on Early Age-related Macular Degeneration
Notal Vision Ltd. 2009
Open access · US-GOV
Comparison Between Home Macular Perimeter (FORESEE HOME) and OCT Visual Field Defects in Patients With CNV
Survey of Ophthalmology 2000
Citation only
Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration
British Medical Bulletin 2008
Citation only
Age-related macular degeneration: diagnosis and management
American Journal of Ophthalmology 2011
Preprint · OA